Filing Flows › ProPhase Labs (PRPH) › Q3 2025
ProPhase Labs (PRPH) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 19, 2025
ProPhase Labs (PRPH) reported revenue of $883K for the third quarter 2025 (Q3 2025), -38% from a year earlier and -29% from the quarter before. Operating margin was -539.5%, net loss $6.8M (774.5% of revenue).
ProPhase Labs, Q3 2025: revenue $883K (-38% year over year), operating margin -539.5%, net loss $6.8M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $883K | -29% | -38% |
| Operating profit | −$4.8M | — | — |
| Net earnings | −$6.8M | — | — |
| Operating cash flow | −$3.5M | — | — |
What changed
Revenue was $883K in Q3 2025, down 38% year over year and down 29% from the previous quarter.
Operating costs exceeded revenue by $4.8M, an operating margin of -539.5%. The quarter ended with a net loss of $6.8M, wider than the previous quarter's $4.5M loss.
Operating cash flow was −$3.5M. Non-cash charges added back $1.0M of depreciation and amortization and $431K of share-based compensation. Working capital and other items added $1.9M.
Questions
What was ProPhase Labs' revenue in the third quarter 2025?
ProPhase Labs (PRPH) reported revenue of $883K for the third quarter 2025 (Q3 2025), -38% from a year earlier and -29% from the quarter before.
Was ProPhase Labs profitable in the third quarter 2025?
Operating loss was $4.8M (-539.5% of revenue) and net loss $6.8M.
Source: ProPhase Labs 10-Q on SEC EDGAR.